Genotyping Assay Market
Genotyping Assay Market - Global Industry Assessment & Forecast
#
Pages:
176
2022
Jan - 2022
VMR-1224
Segments Covered
By
Product & Service Reagents & Kits, Bioinformatics, Genotyping Services, Instruments
-
By
Technology PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, Others
-
By
End-Use Pharmacogenomics, Personalized Medicine and Diagnostics, Animal Genetics, Agricultural Biotechnology, Research and Diagnostic Laboratories, Academic Institutes
-
By
Region North America, Europe, Latin America, Asia Pacific, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 14.36 Billion |
 Revenue 2030:
|
USD 60.52 Billion |
 Revenue CAGR
(2023 - 2030): |
19.70% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Genotyping Assay Market by Product & Service by Technology by End-Use by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 27-Jan-2022
FAQ
Frequently Asked Question
What is the global demand for Genotyping Assay in terms of revenue?
-
The global Genotyping Assay valued at USD 14.36 Billion in 2022 and is expected to reach USD 60.52 Billion in 2030 growing at a CAGR of 19.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Bioline, Qiagen, Danaher, F. Hoffmann-La Roche Ltd., General Electric, Sequenom, Fluidigm, Biogeniq Inc., Envigo, Helix, LGC Biosearch Technologies.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 19.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Genotyping Assay include
- Technological Advancements and Decreasing Prices of DNA Sequencing
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Genotyping Assay in 2022.
